Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,620 | 250 | 0 | 0 | 0 |
| Gross Profit | 11,620 | 250 | N/A | N/A | N/A |
| Operating Expenses | 10,489 | 18,030 | 31,187 | 30,648 | 36,372 |
| Operating Income | 1,131 | -17,780 | -31,187 | -30,648 | -36,372 |
| Other Income | 2,272 | 1,284 | 1,514 | 1,977 | 2,451 |
| Pre-tax Income | 3,403 | -16,496 | -29,673 | -28,671 | -33,921 |
| Income Tax | 145 | 248 | 370 | 0 | 485 |
| Net Income Continuous | 3,258 | -16,744 | -30,043 | -28,671 | -34,406 |
| Net Income | $3,258 | $-16,744 | $-30,043 | $-28,671 | $-34,406 |
| EPS Basic Total Ops | 0.08 | -0.39 | -0.71 | -0.68 | -0.81 |
| EPS Basic Continuous Ops | 0.08 | -0.39 | -0.71 | -0.68 | -0.81 |
| EPS Diluted Total Ops | 0.08 | -0.39 | -0.71 | -0.67 | -0.81 |
| EPS Diluted Continuous Ops | 0.08 | -0.39 | -0.71 | -0.67 | -0.81 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.39 | -0.71 | -0.67 | -0.81 |
| EBITDA(a) | $723 | $-17,217 | $-30,534 | $-31,053 | $-37,284 |